Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial - Ye, N; Jardine, M J; Oshima, M (Circulation, 2021)
et al.